Mark and Olaf receive a KWF grant
Mark and Olaf receive generous support from the Dutch Cancer Society (KWF) to develop a new generation of strategies to make radiotherapy more effective by manipulating the cell cycle.
Read the PRESS RELEASE, the DETAILED DESCRIPTION (in Dutch) and the AWARDED GRANTS of this round.
Cancer research in the spotlight on Radio Swammerdam
Mark appeared on Radio Swammerdam to discuss cancer research in general and his research on brain cancer in particular.
Listen to the broadcast via your favorite podcast platform or SALTO RADIO.
(Dutch only)
Brain cancer covered
We made the cover of Cell Reports Medicine! Our study demonstrates that even though the blood-brain barrier may be physically disrupted, it can still protect brain tumors from therapy.
See the PRESS RELEASE, OUR PAPER and the COVER.
KWF grant awarded to Olaf and Mark
Olaf and Mark were awarded a Dutch Cancer Society (KWF) grant to developing combination therapy approaches aimed at permanently stopping glioblastoma cells from growing.
Read the PRESS RELEASE, the DETAILED DESCRIPTION (in Dutch), our THANK YOU to KWF donors and the AWARDED GRANTS of this round.
AH Second to None Foundation awards research grant to Olaf
Olaf received generous support from the Aniek Hendriksz Second to None Foundation to study combination therapy approaches for malignant brain tumors.
Read on for MORE COVERAGE and a DETAILED DESCRIPTION of Olaf’s plans.
Olaf receives generous support from the STOPHersentumoren Foundation
The STOPHersentumoren funded our plans to study combinations of invasion inhibitors and radiotherapy for treatment of glioblastoma.
See THIS ANOUNCEMENT and the LAYMAN’S SUMMARY of our approach.
KWF grant awarded to Olaf
Olaf was awarded a Dutch Cancer Society (KWF) grant to developing approaches to make radiotherapy more effective for brain tumors.
Read the the DETAILED DESCRIPTION (Dutch) and the AWARDED GRANTS of this round.
How brain cancer cells construct their own highways
We published our paper in collaboration with the Bernards Lab in Cell Reports. We demonstrate how invading glioblastoma cells induce a network of collagens to facilitate their own invasion of the surrounding brain. Importantly, we also identify a way to drug this phenomenon.
Read OUR PAPER, THIS EDITORIAL, THIS EDITORIAL and a POPULAR SCIENCE (p7-8) article covering our findings.
STOPHersentumoren grant awarded to Olaf
Olaf received generous support from the STOPHersentumoren Foundation to investigate whether MPS1 inhibitors could hold promise for brain cancer therapy.
See this PRESS RELEASE.
